LifeMD, Inc. (LFMD)

NASDAQ: LFMD · IEX Real-Time Price · USD
10.82
-0.34 (-3.05%)
At close: Apr 25, 2024, 4:00 PM
10.85
+0.03 (0.28%)
After-hours: Apr 25, 2024, 7:52 PM EDT
-3.05%
Market Cap 436.76M
Revenue (ttm) 152.55M
Net Income (ttm) -23.70M
Shares Out 40.37M
EPS (ttm) -0.70
PE Ratio n/a
Forward PE 32.15
Dividend n/a
Ex-Dividend Date n/a
Volume 394,618
Open 10.95
Previous Close 11.16
Day's Range 10.51 - 11.05
52-Week Range 1.40 - 12.01
Beta 1.43
Analysts Strong Buy
Price Target 12.80 (+18.3%)
Earnings Date May 10, 2024

About LFMD

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair lo... [Read more]

Sector Healthcare
Founded 1994
Employees 207
Stock Exchange NASDAQ
Ticker Symbol LFMD
Full Company Profile

Financial Performance

In 2023, LifeMD's revenue was $152.55 million, an increase of 28.15% compared to the previous year's $119.03 million. Losses were -$23.70 million, -51.27% less than in 2022.

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for LFMD stock is "Strong Buy." The 12-month stock price forecast is $12.8, which is an increase of 18.30% from the latest price.

Price Target
$12.8
(18.30% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

LifeMD to Report First Quarter 2024 Financial Results on May 8

NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ende...

1 day ago - GlobeNewsWire

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividen...

4 weeks ago - GlobeNewsWire

LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference

NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the 23rd Annual Needha...

4 weeks ago - GlobeNewsWire

LifeMD Reports Fourth Quarter 2023 Results

Fourth quarter revenue increased 60% year-over-year to $44.9 million with Telehealth revenues increasing 90% versus the year-ago period. Adjusted EPS of $0.15 per share compared with $0.02 in the year...

6 weeks ago - GlobeNewsWire

LifeMD to Participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the 11th Annual BTIG MedTech, Digital Health, ...

3 months ago - GlobeNewsWire

LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the Maxim Group 2024 Healthcare IT Virtual Con...

3 months ago - GlobeNewsWire

LifeMD Stock Pops on Medifast Agreement. It's All About Weight-Loss Drugs.

The companies are teaming up to offer a ‘transformative weight management solution.'

Other symbols: MED
4 months ago - Barrons

LifeMD's stock soars 9.5% on news company is teaming up with Medifast to create weight-management program that includes GLP-1 drugs

LifeMD Inc.'s stock LFMD, +1.76% soared 9% early Wednesday, after the virtual primary care provider said it's teaming up with Medifast Inc. MED, +1.03%, a wellness company known for its habit-based an...

Other symbols: MED
4 months ago - Market Watch

Medifast Initiates Business Transformation by Entering the Medically Supported Weight Loss Market through Collaboration with LifeMD, a Virtual Primary Care Provider, and Adjusting its Capital Allocation Policy

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today launched the first phase of its business...

Other symbols: MED
4 months ago - Business Wire

LifeMD and Medifast Partner to Offer Transformative Weight Management Solution

Collaboration will integrate LifeMD's telehealth platform and GLP-1 offering for medically qualified patients with OPTA VIA Coach-guided, healthy lifestyle solution

Other symbols: MED
4 months ago - GlobeNewsWire

LifeMD Executives to Participate in RWJBarnabas Health's Telehealth Symposium

NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. ™ (Nasdaq: LFMD), a leading provider of virtual primary care, today announced its participation in the RWJBarnabas Health Telehealth Symposium ...

5 months ago - GlobeNewsWire

LifeMD Reports Third Quarter 2023 Results; Record Revenue and Adjusted EBITDA

Revenue increased 23% year-over-year to $38.6 million with both telehealth and WorkSimpli achieving record revenues. Adjusted EPS of $0.08 per share compared with a loss of $0.03 in the year-ago perio...

6 months ago - GlobeNewsWire

Particle Health and LifeMD Demonstrate the Potential of Using Comprehensive Electronic Health Record Data to Triage Patients for GLP-1 Weight Management Therapy

Joint Research Study Proved Particle's Platform Can Help Providers Contextualize and Comprehend Patient Data to Improve Care and Identify Those Eligible for GLP-1 Treatment Joint Research Study Proved...

7 months ago - GlobeNewsWire

LifeMD and ASCEND Therapeutics Launch Integrated Direct-to-Consumer Telehealth Model for Hormone Therapy

NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today launched a partnership with ASCEND Therapeutics US, LLC, a subsidia...

7 months ago - GlobeNewsWire

LifeMD to Participate in Two Investor Conferences in September

NEW YORK, Aug. 30, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) today announced that management will be participating in two upcoming investor conferences in September.

8 months ago - GlobeNewsWire

LifeMD Reports Second Quarter 2023 Results; Achieves Positive Free Cash Flow and Raises 2023 Revenue Guidance

Revenue grew 18% year-over-year to a record $35.9 million; telehealth net revenues increased 11% versus the first quarter of 2023. Achieved positive free cash flow, ahead of guidance.

9 months ago - GlobeNewsWire

LifeMD to Report Second Quarter 2023 Financial Results on August 9

NEW YORK, July 26, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended...

9 months ago - GlobeNewsWire

LifeMD Elevates Successful GLP-1 Weight Management Program with Proprietary Platform Enhancements

Proprietary platform enhancements elevate LifeMD's GLP-1 weight management program with best-in-class clinician-directed care and personalized guidance Proprietary platform enhancements elevate LifeMD...

10 months ago - GlobeNewsWire

LifeMD Appoints William J. Febbo to its Board of Directors

NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the appointment of William (Will) J. Febbo, Chief Executiv...

11 months ago - GlobeNewsWire

LifeMD, Inc. to Present at the June 1st Virtual Investor Summit

New York, New York--(Newsfile Corp. - May 23, 2023) - LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that LifeMD management will participate in the virtua...

1 year ago - Newsfile Corp

LifeMD, Inc. Reports First Quarter 2023 Results; Record Revenues and Adjusted EBITDA

NEW YORK, May 12, 2023 (GLOBE NEWSWIRE) --   LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, reported results for the first quarter ended March 31, 2023. All figure compar...

1 year ago - GlobeNewsWire

LifeMD and HealthWarehouse.com Partner in Exclusive Telehealth Agreement

NEW YORK, May 08, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading provider of virtual primary care services, today announced that it has entered into an agreement to be the exclusive t...

1 year ago - GlobeNewsWire

LifeMD, Inc. to Announce First Quarter 2023 Financial Results on May 12, 2023

NEW YORK, May 03, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it will report its financial results for the first ...

1 year ago - GlobeNewsWire

LifeMD Launches New Features and Membership Plans to Improve Patient Experience and Broaden Access to Healthcare

NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading provider of virtual primary care services, today announced the launch of new membership plans that enable immediate ...

1 year ago - GlobeNewsWire

LifeMD, Inc. Reports Fourth Quarter/ Full Year 2022 Results; Achieves Consolidated Adjusted EBITDA Profitability

NEW YORK, March 22, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, reported results for the fourth quarter and full year ended December 31, 2022....

1 year ago - GlobeNewsWire